Vironics, Inc. is dedicated to the discovery, development and worldwide distribution of drugs, medical products and technologies for the biotechnology and pharmaceutical industries.
- Licensing of Emerging Biological Medications
- Fundamental Research and Drug Development
- Clinical Trials and New Drug Licensing
- Medical Technolgies
- Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
- Vironics signed definitive agreement with over 50 EMS units in China to collaborate various educational and training sessions in ACLS, emergency response effort.
Vironics is actively pursuing the identification of novel targets for anti-viral and anti-cancer drugs. Research activities are guided by the Scientific Advisory Board, which includes internationally recognized authorities in virology, cell biology, molecular biology and medicine.